Letters to the Editor

Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes

Department of Haematology, King’s College Hospital, London
Department of Haematology, University College London Hospitals, London, UK; UCL Cancer Institute, University College London, London
Department of Haematology, Freeman Hospital, Newcastle University, Newcastle
Department of Haematology, Manchester Royal Infirmary, Manchester
Department of Haematology, University College London Hospitals, London
Department of Medical Oncology, The Christie Hospital, Manchester
Department of Haematology, University Hospitals Bristol and Weston, Bristol
Department of Haematology, Queen Elizabeth Hospital, Birmingham
Department of Haematology, Royal Marsden Hospital, London
Department of Haematology. University Hospital of Wales, Cardiff
Department of Haematology, Queen Elizabeth Hospital, Glasgow
Department of Haematology, Cambridge University Hospitals, Cambridge
Department of Haematology, Leeds Teaching Hospitals, Leeds
Department of Haematology, Freeman Hospital, Newcastle University, Newcastle
Department of Haematology, Queen Elizabeth Hospital, Birmingham
Department of Haematology, University College London Hospitals, London
Department of Haematology, King’s College Hospital, London, UK; Comprehensive Cancer Centre, King’s College London, London
Department of Haematology, Manchester Royal Infirmary, Manchester
Department of Haematology, The Christie Hospital, Manchester
Department of Haematology, University Hospitals Bristol and Weston, Bristol
Department of Haematology, King’s College Hospital, London
CR UK and UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London
Department of Haematology, King’s College Hospital, London
Haematologica Early view Apr 4, 2024 https://doi.org/10.3324/haematol.2024.285010